Alliancebernstein L.P. Astrazeneca PLC Transaction History
Alliancebernstein L.P.
- $261 Billion
- Q1 2025
A detailed history of Alliancebernstein L.P. transactions in Astrazeneca PLC stock. As of the latest transaction made, Alliancebernstein L.P. holds 2,186,681 shares of AZN stock, worth $161 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,186,681
Previous 3,101,025
29.49%
Holding current value
$161 Million
Previous $203 Million
20.9%
% of portfolio
0.06%
Previous 0.07%
Shares
29 transactions
Others Institutions Holding AZN
# of Institutions
1,421Shares Held
508MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.2 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.99 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.62 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.34 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.3 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...